Credo Ventures is a venture capital firm active globally. The page below shows 4 Power Law outcomes from Credo Ventures's portfolio — 4 unicorns ($1B+ valuation) and 0 additional thoroughbreds (companies that crossed $100M+ in revenue without yet reaching $1B+ valuation).
Outcomes are concentrated in AI · Health Tech & Medtech; top portfolio geographies are USA · UK. Credo ranks #58 in EMEA in the 2026 Dealroom Power Law Investor Ranking by cross-stage outcomes.
The 4 Credo Power Law outcomes ($100M+ revenue and above).
Snapshot of where the outcomes are concentrated by country, sector, and stage entered.
-
USA2
-
UK2
-
AI3
-
Health Tech & Medtech1
-
Seed4
Credo's 4 Power Law outcomes.
Toggle between a sector landscape and a world map. Both views respond to the stage and outcome-tier filters. The faded names at the bottom of bigger boxes are part of the full list — click "+ N more" to reveal them.
Where Credo's founders come from — and where they study.
8 founders across the 4 Power Law outcomes — split by country of origin, university attended, and the company they worked at before founding. University of Bucharest and GoodData are the deepest single pipelines.
How does Credo stack up?
Credo in orange, your selection in blue and other colours. Pick from the global roster of 35 peer investors — filter by region or hit "Find similar shapes" to auto-pick the three closest. The funnel matrix mirrors the spider chart on the ranking page; the line chart shows each firm's share of global unicorns minted that year — peaks reveal vintage years.
Stage focus
Companies by entry stage and outcome tierSector focus
Companies per investor across the 10 highest-volume sectorsShare of new unicorns per year
% of all global unicorns minted that year, year by yearWant the full picture on Credo Ventures?
The Dealroom platform tracks every round, every co-investor, and every portfolio company in real time — across 25,000+ investors and 3M+ companies globally.